Cancer Crosslinks 2010 attracted more than 180 participants from all over Norway to the New Research Building at Radium Hospital.

Building on the success of the first event in 2009 Cancer Crosslinks is now established as annual meeting place for Norwegian researchers and clinicians to present and discuss latest oncology research and its clinical implications. This year’s program had two core sessions focusing on Resistance and Immunotherapy that featured excellent presentations sharing recent research, clinical results and actively addressed the interface between oncologists and hematologists.

The interdisciplinary audience enjoyed stimulating discussions and lively mingling opportunities and the compact one day meeting was rounded off with a vibrant Networking evening allowing participants to intensify existing and build new relationships. The meeting also attracted many representatives from Oslo Cancer Cluster’s member companies contributing to stimulating exchange between the academic, clinical and commercial side.

Cancer Crosslinks was organized in partnership between Oslo Cancer Cluster, Bristol-Myers-Squibb and Clavis Pharma and will be continued with Cancer Crosslinks 2011 in January next year!